share_log

Rigetti Computing | 424B5: Prospectus

SEC announcement ·  Mar 15 08:45
Summary by Moomoo AI
Rigetti Computing, Inc. (Rigetti), a company specializing in quantum computing, has entered into a sales agreement with Needham & Company, LLC and B. Riley Securities, Inc., acting as sales agents, to offer and sell up to $100,000,000 of its common stock. The common stock is quoted on The Nasdaq Capital Market under the symbol 'RGTI.' The sales agreement, dated March 15, 2024, allows Rigetti to sell its shares through an 'at the market offering' as defined by Rule 415(a)(4) under the Securities Act of 1933. The sales agents will use commercially reasonable efforts to sell the shares on mutually agreed terms, and are not obligated to sell any specific number or dollar amount. The compensation for the sales agents will be up to 3.0% of the...Show More
Rigetti Computing, Inc. (Rigetti), a company specializing in quantum computing, has entered into a sales agreement with Needham & Company, LLC and B. Riley Securities, Inc., acting as sales agents, to offer and sell up to $100,000,000 of its common stock. The common stock is quoted on The Nasdaq Capital Market under the symbol 'RGTI.' The sales agreement, dated March 15, 2024, allows Rigetti to sell its shares through an 'at the market offering' as defined by Rule 415(a)(4) under the Securities Act of 1933. The sales agents will use commercially reasonable efforts to sell the shares on mutually agreed terms, and are not obligated to sell any specific number or dollar amount. The compensation for the sales agents will be up to 3.0% of the gross proceeds from any shares sold. This move is part of Rigetti's strategy to raise capital for working capital, capital expenditures, and general corporate purposes. The company is considered an 'emerging growth company' and a 'smaller reporting company,' opting for reduced public company reporting requirements. Investing in Rigetti's common stock involves a high degree of risk, as detailed in the 'Risk Factors' section of the prospectus supplement.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more